BMRN — Evaluation History

BioMarin Pharmaceutical Inc.

Deterministic Evaluations last 3 months

7 records

Date	Strategy	Price	Decision	Conf	Tech	Macro	Sector	Earn	Regime	Rationale
11 Mar 2026	minervini	$60.89	HOLD	66%	66	70	75	50	Neutral	Market regime: Neutral. Position remains valid. Continue holding with existing stop loss.
11 Mar 2026	momentum	$60.89	HOLD	54%	54	70	75	50	Neutral	Market regime: Neutral. MACD: 0.5778 vs Signal: 0.7837. RSI: 46.0. Holding — +5.79% (5d). Entry $57.56 \| Current $60.89 \| Peak $61.12 (+6.18%) \| -0.4% from peak. MAs: EMA21 $60.42 \| SMA50 $59.07 (+F1%) \| SMA100 $56.58 \| SMA200 $56.62. MACD 0.578 / Signal 0.784 / Hist -0.206. RSI 46.0. Volume 0.6× avg (1,235,200). No exit signal.
10 Mar 2026	minervini	$60.88	HOLD	64%	64	70	75	50	Neutral	Market regime: Neutral. Position remains valid. Continue holding with existing stop loss.
10 Mar 2026	momentum	$60.88	HOLD	63%	63	70	75	50	Neutral	Market regime: Neutral. MACD: 0.6097 vs Signal: 0.8352. RSI: 53.4. Holding — +5.77% (4d). Entry $57.56 \| Current $60.88 \| Peak $61.12 (+6.18%) \| -0.4% from peak. MAs: EMA21 $60.37 \| SMA50 $59.06 (+F1%) \| SMA100 $56.49 \| SMA200 $56.61. MACD 0.610 / Signal 0.835 / Hist -0.226. RSI 53.4. Volume 0.6× avg (1,301,000). No exit signal.
09 Mar 2026	minervini	$61.12	HOLD	65%	65	70	75	50	Neutral	Market regime: Neutral. Position remains valid. Continue holding with existing stop loss.
09 Mar 2026	momentum	$61.12	HOLD	62%	62	70	75	50	Neutral	Market regime: Neutral. MACD: 0.6427 vs Signal: 0.8916. RSI: 54.6. Holding — +6.18% (3d). Entry $57.56 \| Current $61.12 \| Peak $61.12 (+6.18%) \| -0.0% from peak. MAs: EMA21 $60.32 \| SMA50 $59.06 (+F1%) \| SMA100 $56.41 \| SMA200 $56.60. MACD 0.643 / Signal 0.892 / Hist -0.249. RSI 54.6. Volume 1.2× avg (2,630,900). No exit signal.
05 Mar 2026	minervini	$60.43	HOLD	72%	67	70	90	50	Neutral	Market regime: Neutral. Position remains valid. Continue holding with existing stop loss.

AI Evaluations last 3 months

1 records

Date	Price	Decision	Conf	Model	Rationale
05 Mar 2026	$60.43	HOLD	62%	claude-sonnet-4-6	BMRN is held with a 4.99% unrealized gain from an entry at $57.56, and the current technical setup warrants holding rather than adding or exiting. The stock is above key moving averages and has consolidated constructively, but the below-average volume on today's rally, flat RSI, non-rising SMA200, and deeply negative 12-month relative strength collectively argue against increasing the position aggressively at this level. The stop at $52.96 provides defined downside protection, and with the stock sitting below its 52-week high of $66.28, there is room for further appreciation if institutional sponsorship improves. A HOLD is appropriate: protect the existing gain, allow the trend to develop, and reassess on a high-volume breakout above $63-$64 or a close below the SMA50 at $59.

An error has occurred. This application may no longer respond until reloaded. Reload 🗙